Updated Jul 16, 2026
Ward Scott R. has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — buying. Lifetime open-market purchases: $103K.

Scott R. Ward serves as a director of InspireMD, Inc. (NSPR). In the latest SEC filing dated 2026-01-16, he is listed as a member of the board with no reported securities purchases or sales, and no further transactional activity noted. InspireMD focuses on proprietary MicroNet stent platform technology for vascular and coronary disease, including the CGuard carotid embolic prevention system and the MGuard Prime embolic protection system.
| Role | Insider |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-19 | MMSI | MERIT MEDICAL SYSTEMS INC | A — Grant or award | 3.5K | $0.00 | |
| 2026-05-08 | NSPR | InspireMD, Inc. | P — Open-market purchase | 73.3K | $1.15 | $84K |
| 2026-05-08 | NSPR | InspireMD, Inc. | P — Open-market purchase | 16.0K | $1.15 | $18K |
| 2026-01-16 | NSPR | InspireMD, Inc. | A — Grant or award | 88.1K | $0.00 |
Scott R. Ward serves as a director of InspireMD, Inc. (NSPR). In the latest SEC filing dated 2026-01-16, he is listed as a member of the board with no reported securities purchases or sales, and no further transactional activity noted. InspireMD focuses on proprietary MicroNet stent platform technology for vascular and coronary disease, including the CGuard carotid embolic prev…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 2 open-market purchases ($103K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Ward Scott R. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.